Q3 2025 Holdings
Filed 2025-11-14 | 18 holdings | $763.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $184.6M | 8,118,892 | 24.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $123.3M | 1,451,924 | 16.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $105.1M | 2,772,654 | 13.8% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $63.0M | 1,525,730 | 8.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $49.7M | 1,064,249 | 6.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $45.4M | 1,131,205 | 5.9% |
| Agios Pharmaceuticals Inc(AGIO)Put | COM | 00847X104 | $39.1M | 975,000 | 5.1% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $38.7M | 2,636,609 | 5.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $25.4M | 4,138,943 | 3.3% |
| Merus N V | COM | N5749R100 | $20.4M | 216,954 | 2.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.8M | 444,565 | 2.3% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $13.5M | 1,435,130 | 1.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $10.6M | 833,333 | 1.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $9.7M | 696,825 | 1.3% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $8.0M | 236,383 | 1.0% |
| Verrica Pharmaceuticals Inc(VRCA) | COM SHS | 92511W207 | $4.0M | 923,910 | 0.5% |
| Sellas Life Sciences Group I(SLS)Call | COM NEW | 81642T209 | $3.7M | 2,300,000 | 0.5% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $1.4M | 227,174 | 0.2% |